Alzamend Neuro, Inc.
Alzamend Neuro, Inc. (ALZN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALZN · as of Jun 8, 2026
Key Statistics
Explore Alzamend Neuro, Inc. Data
alzn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
alzn competitorsALZN
ACXP
ADIL
APRE
BCDA
CDIOStock Performance
Full HistoryAbout Alzamend Neuro, Inc.
Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical firm dedicated to advancing therapeutic solutions for neurodegenerative and psychiatric illnesses. Its development pipeline features t…
what is alzamend neuro, inc. · alzn stock overview · alzamend neuro, inc. company profile · who is alzamend neuro, inc. ceo · alzn NASDAQ · alzamend neuro, inc. headquarters · alzamend neuro, inc. business segments
About Stock Overview & Key Data
Alzamend Neuro, Inc. (ALZN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 15, 2021. As of the latest trading session, ALZN stock price is $1.16, with a market capitalization of $3.6M. The stock has returned -66.38% over the past 12 months and -36.26% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Alzamend Neuro, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Alzamend Neuro, Inc. reported revenue of — and net income of -$4.5M. For detailed data — including Alzamend Neuro, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alzamend Neuro, Inc. (ALZN) stock price is $1.16. The stock is traded on NASDAQ under the ticker symbol ALZN. The 52-week range is $0.84 – $4.00.